Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fábio S. Possebon"'
Autor:
Pollyana R.C. Braga, Roberta M. Basso, Lorrayne S.A. Martins, Marcio G. Ribeiro, Ariadne F. Amarante, Monique R.T. Casas, Alessandra F.C. Nassar, Juliano G. Pereira, José Carlos F. Pantoja, Fabricio M. Cerri, Fábio S. Possebon, José P. Oliveira-Filho, Alexandre S. Borges
Publikováno v:
Pesquisa Veterinária Brasileira, Vol 43 (2023)
ABSTRACT: The present study investigated Salmonella spp. in the feces of 200 foals up to one year of age (100 with clinical signs of diarrhea and 100 without clinical signs of diarrhea). Bacteriological culture, serotyping, antimicrobial susceptibili
Externí odkaz:
https://doaj.org/article/f0668f8d55df4abea9a6584a3a0f859a
Autor:
João B.P. Guerra Filho, Ricardo S. Yamatogi, Fábio S. Possebon, Sueli A. Fernandes, Monique R. Tiba-Casas, Gustavo H.B. Lara, Márcio G. Ribeiro, José P.A.N. Pinto
Publikováno v:
Pesquisa Veterinária Brasileira, Vol 36, Iss 12, Pp 1165-1170
ABSTRACT: Salmonellosis is a foodborne disease caused by bacteria of the genus Salmonella, being pigs and pork-products potentially important for its occurrence. In recent decades, some serovars of Salmonella have shown increase of resistance to conv
Externí odkaz:
https://doaj.org/article/87367b2086fc42e68961a396eda6fcd3
Autor:
Natália C, Gaeta, Alexandre, Hellmeister, Fábio S, Possebon, João P, Araujo, Marcos B, Heinemann
Publikováno v:
Veterinary research communications.
Staphylococcus epidermidis is an emerging pathogen causing infant pyelonephritis. There is a lack of genomic data on Staphylococcus epidermidis as the etiology of pyelonephritis and its resistant determinants. In this study, we have conducted a genom
Autor:
Natália C. Gaeta, Alexandre Hellmeister, Fábio S. Possebon, João P. Araujo, Marcos B. Heinemann
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e31cf25c43134c6821cf62e57faf56
Autor:
Cassia F. Estofolete, Cecilia A. Banho, Guilherme R. F. Campos, Beatriz de C. Marques, Livia Sacchetto, Leila S. Ullmann, Fabio S. Possebon, Luana F. Machado, Juliana D. Syrio, João P. Araújo Junior, Cintia Bittar, Paula Rahal, Suzana M. A. Lobo, Helena Lage Ferreira, Nikos Vasilakis, Mauricio L. Nogueira
Publikováno v:
Viruses, Vol 13, Iss 7, p 1237 (2021)
The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-C
Externí odkaz:
https://doaj.org/article/1dcfd1b406244f93a83af1050fdfd1c1